Rapid Sertraline Discontinuation and Tinnitus
Tinnitus is not a typical feature of sertraline discontinuation syndrome, though it has been rarely reported as both a side effect during treatment and upon withdrawal.
Understanding Sertraline Discontinuation Syndrome
Sertraline is associated with a well-documented discontinuation syndrome when stopped abruptly or tapered too rapidly 1. The FDA label and clinical guidelines clearly characterize this syndrome with specific symptoms including:
- Neurological symptoms: dizziness, vertigo, sensory disturbances, paresthesias (electric shock sensations), headache
- Psychiatric symptoms: anxiety, irritability, agitation, emotional lability, insomnia, confusion
- Somatic symptoms: fatigue, lethargy, general malaise, myalgias, chills
- Gastrointestinal symptoms: nausea, vomiting, diarrhea 2
Notably, tinnitus is not listed among the characteristic symptoms of sertraline discontinuation syndrome in either the FDA labeling or major clinical practice guidelines 1, 2.
Evidence Linking Sertraline to Tinnitus
During Treatment
Research evidence suggests sertraline can rarely cause tinnitus as a side effect during active treatment:
- A case report documented bilateral tinnitus developing after several weeks of sertraline 50 mg daily, which completely resolved after discontinuation 3
- A large pharmacovigilance study analyzing the FDA's FAERS database found higher reporting rates of tinnitus associated with multiple antidepressants including sertraline 4
- The mechanism may involve serotonin's role in auditory filtering through complex interactions between serotonergic, glutamatergic, and GABAergic systems in the cochlea 3
Upon Withdrawal
The literature on tinnitus specifically associated with sertraline withdrawal is extremely limited:
- One review article mentions "tinnitus associated with withdrawal of antidepressants (venlafaxine and sertraline)" but provides minimal detail 5
- This represents isolated case report level evidence rather than systematic documentation
Clinical Implications and Pitfalls
Common pitfall: Attributing any new symptom during or after SSRI discontinuation to withdrawal syndrome. While sertraline discontinuation causes multiple neurological and sensory symptoms, tinnitus is not a recognized component.
If tinnitus develops during sertraline taper or discontinuation, consider:
- Temporal relationship: Did tinnitus begin during active treatment or only after dose reduction/discontinuation?
- Alternative causes: Evaluate for primary tinnitus etiologies (hearing loss, acoustic trauma, ototoxic medications, vascular causes) 6, 7
- Concurrent medications: Check for other ototoxic agents, particularly aspirin/NSAIDs which may have synergistic effects 3
- Psychiatric comorbidity: Anxiety and depression commonly co-occur with tinnitus and may be unmasked during antidepressant withdrawal 6
Management Approach
If tinnitus emerges during sertraline discontinuation:
- Do not assume it is part of typical discontinuation syndrome
- Slow or pause the taper to assess whether symptoms stabilize
- Conduct appropriate evaluation including audiometry and otologic examination if tinnitus persists 6, 7, 8
- Resume previous dose if tinnitus is severe and other discontinuation symptoms are present, then taper more gradually (reduce dose by 25% every 1-2 weeks rather than abrupt cessation) 2
- Distinguish from other discontinuation symptoms: The presence of characteristic withdrawal features (dizziness, paresthesias, flu-like symptoms) supports discontinuation syndrome, while isolated tinnitus suggests an alternative etiology
The evidence suggests that while sertraline can rarely cause tinnitus during treatment, tinnitus specifically triggered by rapid discontinuation is poorly documented and should prompt evaluation for other causes rather than being reflexively attributed to withdrawal syndrome.